Change of leadership at Versantis and other Swiss startups

As of January 2022, three CEOs and one president will assume responsibility in the Swiss startups, Bitcoin Suisse, Aktionariat, Versantis and Abhahti. Versantis, a clinical-stage biotechnology company developing novel therapies for orphan liver and pediatric diseases, appointed Mark J. Fitzpatrick as Chief Executive Officer and member of the board of directors.
Article on Startupticker